MedTrace Logo

The ONCOCAMP Study

NCT06270602 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2025-12-22

No results posted yet for this study

Summary

The present study is a retrospective-prospective observational and multicentric study aiming to collect data relating to all patients included in the ROC platform. All ROC centers will be involved in the present study.

Conditions

Interventions

OTHER

Data collection (retrospective)

Collection of patient data entered in the ROC platform from the beginning activation of the platform (November 2018) until the date on which the study is approved by the local ethics committee

OTHER

Data collection (prospective)

Collection of patient data entered in the ROC platform from the date in which the study is approved by the local ethical committee

Sponsors & Collaborators

  • National Cancer Institute, Naples

    lead OTHER

Principal Investigators

  • Sandro Pignata, M.D. · IRCCS I.N.T. "G. Pascale"

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-14
Primary Completion
2026-05-31
Completion
2026-07-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06270602 on ClinicalTrials.gov